The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing.
Research at Michigan State University, published in the Journal of Biological Chemistry, shows that a small “molecular tweezer” keeps proteins from clumping, or aggregating, the first step of neurological disorders such as Parkinson’s disease, Alzheimer’s disease and Huntington’s disease.
The results are pushing the promising molecule toward clinical trials and actually becoming a new drug, said Lisa Lapidus, MSU associate professor of physics and astronomy and co-author of the paper.
“By the time patients show symptoms and go to a doctor, aggregation already has a stronghold in their brains,” she said. “In the lab, however, we can see the first steps, at the very place where the drugs could be the most effective. This could be a strong model for fighting Parkinson’s and other diseases that involve neurotoxic aggregation.”
Lapidus’ lab uses lasers to study the speed of protein reconfiguration before aggregation, a technique Lapidus pioneered. Proteins are chains of amino acids that do most of the work in cells. Scientists understand protein structure, but they don’t know how they are built – a process known as folding.
Lapidus’ lab has shed light on the process by correlating the speed at which an unfolded protein changes shape, or reconfigures, with its tendency to clump or bind with other proteins. If reconfiguration is much faster or slower than the speed at which proteins bump into each other, aggregation is slow, but if reconfiguration is the same speed, aggregation is fast.
Srabasti Acharya, lead author and doctoral candidate in Lapidus’ lab, tested the molecule, CLR01, which was patented jointly by researchers at the University of Duisburg-Essen (Germany) and UCLA. CLR01 binds to the protein and prevents aggregation by speeding up reconfiguration. It’s like a claw that attaches to the amino acid lysine, which is part of the protein.
This work was preceded by Lapidus’ research involving the spice curcumin. While the spice molecules put the researchers on a solid path, the molecules weren’t viable drug candidates because they cannot cross the blood-brain barrier, or BBB, the filter that controls what chemicals reach the brain.
It’s the BBB, in fact, that disproves the notion that people should simply eat more spicy food to stave off Parkinson’s disease.
Spicy misconceptions notwithstanding, CLR01 mimics curcumin molecules’ ability to prevent aggregation. But unlike the spice, CLR01 can crossover the BBB and treat its targeted site. Not only do they go to the right place, but CLR01 molecules also work even better because they speed up reconfiguration even more than curcumin. Additionally Acharya showed that CLR01 slows the first step of aggregation, and the results from the study map out a clear road map for moving the drug to clinical trials.
Hearing about a nontraditional physics lab that was advancing medicine is what brought Acharya to work with Lapidus.
“I knew I wanted to study physics when I came to MSU, but when I heard Dr. Lapidus’ presentation during orientation, I knew this is what I wanted to do,” Acharya said. “We are using physics to better understand biology to help cure actual diseases.”
To help move the research to the next phase, Gal Bitan, co-author and professor at UCLA, is using crowdsourcing to raise funds for the clinical trials. Log on to the indiegogo.com website for more information.
The Latest on: Parkinson’s
[google_news title=”” keyword=”Parkinson’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Parkinson’s
- Putin likely has Parkinson’s – his days are numbered & he’ll come to a violent sudden end, warns ex-MI6 chiefon February 3, 2023 at 11:17 pm
SICK Vladimir Putin’s “days are numbered” as the tyrant faces being carted off to hospital in a “sudden end” to his rule, the former head of MI6 has warned.
- Harrison Ford's Character on 'Shrinking' Has Parkinson's — but Does the Actor?on February 3, 2023 at 8:51 am
Does Harrison Ford have Parkinson's Disease? His 'Shrinking' character does, but does the actor also have the illness? Learn more here.
- Deep Brain Stimulation in Parkinson's Disease Market Understand Key Trend, Top Competitors Data and Opportunities till Upcoming Years 2028on February 3, 2023 at 12:48 am
Deep Brain Stimulation in Parkinson's Disease Market report's in-depth analysis of the restraints shows how they ...
- Does Harrison Ford Have Parkinson's Disease? No, But Here's What Inspired His 'Shrinking' Character's Diagnosison February 2, 2023 at 11:45 am
As Ford’s character Paul juggles work, friendships, and family, we watch him cope and learn to live with his Parkinson’s diagnosis. Ford’s performance in the series is so phenomenal that some fans ...
- Milford resident's new business focuses on Parkinson's therapyon February 1, 2023 at 3:27 pm
Rey Abdilla, a physical therapist by trade, had long sought the opportunity to truly focus on aiding older adults and those suffering the lasting effects of strokes or Parkinson's disease. In the end, ...
- Pedaling for Parkinson'son February 1, 2023 at 3:06 pm
In this week’s Wellness Wednesday, we take you to Intermountain Health’s Live Well Center, where patients with Parkinson’s disease are relieving their symptoms not with medicine but with bicycles.
- The Sound Center launches video series for people with Parkinson's diseaseon January 31, 2023 at 1:22 pm
The Sound Center in Oak Brook recently released of a new video series for people with Parkinson's disease. Do you or a loved one have Parkinson's disease? Do you want to find helpful treatments for ...
- For Parkinson’s disease, a remedy under my skinon January 31, 2023 at 12:04 pm
Mr. Roboto I’m not. But Deep Brain Stimulation has given me hope — and more than a little affinity for the mechanical creatures that transfixed me in my youth.
- Algorithm suggests altered speech may be early sign of Parkinson’s diseaseon January 31, 2023 at 6:42 am
Changes in speech and voice might be the first sign of Parkinson's disease, according to an algorithm designed to facilitate early diagnosis.
- Parkinson's Research Newson January 30, 2023 at 4:00 pm
Jan. 10, 2023 — New research says the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease. The findings show a wide imbalance in microbiome composition in ...
via Bing News